Logo image of NMAX

NEWSMAX INC (NMAX) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:NMAX - US65250K1051 - Common Stock

8.3 USD
+0.09 (+1.1%)
Last: 11/28/2025, 7:51:00 PM
8.35 USD
+0.05 (+0.6%)
After Hours: 11/28/2025, 7:51:00 PM
Fundamental Rating

3

Taking everything into account, NMAX scores 3 out of 10 in our fundamental rating. NMAX was compared to 97 industry peers in the Media industry. NMAX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, NMAX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

NMAX had negative earnings in the past year.
NMAX Yearly Net Income VS EBIT VS OCF VS FCFNMAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

The Return On Assets of NMAX (-77.73%) is worse than 84.69% of its industry peers.
NMAX has a worse Return On Equity (-171.17%) than 74.49% of its industry peers.
Industry RankSector Rank
ROA -77.73%
ROE -171.17%
ROIC N/A
ROA(3y)-53.26%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NMAX Yearly ROA, ROE, ROICNMAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 200 -200 400 600 800

1.3 Margins

Looking at the Gross Margin, with a value of 45.23%, NMAX is in line with its industry, outperforming 54.08% of the companies in the same industry.
NMAX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NMAX Yearly Profit, Operating, Gross MarginsNMAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 20 -20 40 -40

6

2. Health

2.1 Basic Checks

NMAX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NMAX has about the same amount of shares outstanding.
NMAX has a better debt/assets ratio than last year.
NMAX Yearly Shares OutstandingNMAX Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M 80M 100M
NMAX Yearly Total Debt VS Total AssetsNMAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M

2.2 Solvency

NMAX has an Altman-Z score of 2.71. This is not the best score and indicates that NMAX is in the grey zone with still only limited risk for bankruptcy at the moment.
NMAX's Altman-Z score of 2.71 is amongst the best of the industry. NMAX outperforms 82.65% of its industry peers.
NMAX has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of NMAX (0.00) is better than 88.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.71
ROIC/WACCN/A
WACC8.66%
NMAX Yearly LT Debt VS Equity VS FCFNMAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 -20M -40M

2.3 Liquidity

NMAX has a Current Ratio of 2.74. This indicates that NMAX is financially healthy and has no problem in meeting its short term obligations.
NMAX's Current ratio of 2.74 is amongst the best of the industry. NMAX outperforms 88.78% of its industry peers.
NMAX has a Quick Ratio of 2.71. This indicates that NMAX is financially healthy and has no problem in meeting its short term obligations.
NMAX has a better Quick ratio (2.71) than 88.78% of its industry peers.
Industry RankSector Rank
Current Ratio 2.74
Quick Ratio 2.71
NMAX Yearly Current Assets VS Current LiabilitesNMAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 20M 40M 60M 80M 100M

4

3. Growth

3.1 Past

NMAX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -68.55%.
Looking at the last year, NMAX shows a very strong growth in Revenue. The Revenue has grown by 26.42%.
EPS 1Y (TTM)-68.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)26.42%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, NMAX will show a very strong growth in Earnings Per Share. The EPS will grow by 21.73% on average per year.
The Revenue is expected to grow by 13.51% on average over the next years. This is quite good.
EPS Next Y-18.23%
EPS Next 2Y38.21%
EPS Next 3Y27.01%
EPS Next 5Y21.73%
Revenue Next Year7.53%
Revenue Next 2Y10.86%
Revenue Next 3Y11.35%
Revenue Next 5Y13.51%

3.3 Evolution

NMAX Yearly Revenue VS EstimatesNMAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M 250M
NMAX Yearly EPS VS EstimatesNMAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 0 -0.2 -0.4 -0.6

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NMAX. In the last year negative earnings were reported.
Also next year NMAX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NMAX Price Earnings VS Forward Price EarningsNMAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NMAX Per share dataNMAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

NMAX's earnings are expected to grow with 27.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.21%
EPS Next 3Y27.01%

0

5. Dividend

5.1 Amount

NMAX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NEWSMAX INC

NYSE:NMAX (11/28/2025, 7:51:00 PM)

After market: 8.35 +0.05 (+0.6%)

8.3

+0.09 (+1.1%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)11-13 2025-11-13/amc
Earnings (Next)03-30 2026-03-30
Inst Owners29.39%
Inst Owner Change20.39%
Ins OwnersN/A
Ins Owner Change0%
Market Cap1.07B
Revenue(TTM)308.03M
Net Income(TTM)-181.37M
Analysts82.5
Price Target21.93 (164.22%)
Short Float %2.73%
Short Ratio2.41
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1367.09%
Min EPS beat(2)-2792.16%
Max EPS beat(2)57.98%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.16%
Min Revenue beat(2)0.92%
Max Revenue beat(2)1.4%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)7.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-215.22%
Revenue NQ rev (1m)-1.28%
Revenue NQ rev (3m)-1.28%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.16%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.48
P/FCF N/A
P/OCF N/A
P/B 10.11
P/tB 10.11
EV/EBITDA N/A
EPS(TTM)-1.41
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.39
BVpS0.82
TBVpS0.82
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -77.73%
ROE -171.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.23%
FCFM N/A
ROA(3y)-53.26%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.32
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.74
Quick Ratio 2.71
Altman-Z 2.71
F-ScoreN/A
WACC8.66%
ROIC/WACCN/A
Cap/Depr(3y)90.3%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.87%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-18.23%
EPS Next 2Y38.21%
EPS Next 3Y27.01%
EPS Next 5Y21.73%
Revenue 1Y (TTM)26.42%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year7.53%
Revenue Next 2Y10.86%
Revenue Next 3Y11.35%
Revenue Next 5Y13.51%
EBIT growth 1Y-229.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year79.59%
EBIT Next 3Y28.86%
EBIT Next 5Y25.53%
FCF growth 1Y-946.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1170.71%
OCF growth 3YN/A
OCF growth 5YN/A

NEWSMAX INC / NMAX FAQ

Can you provide the ChartMill fundamental rating for NEWSMAX INC?

ChartMill assigns a fundamental rating of 3 / 10 to NMAX.


What is the valuation status for NMAX stock?

ChartMill assigns a valuation rating of 1 / 10 to NEWSMAX INC (NMAX). This can be considered as Overvalued.


What is the profitability of NMAX stock?

NEWSMAX INC (NMAX) has a profitability rating of 0 / 10.


How financially healthy is NEWSMAX INC?

The financial health rating of NEWSMAX INC (NMAX) is 6 / 10.